Obokata issues statement

Obokata issues statement

TOKYO, Japan - Photo shows Haruko Obokata, a researcher with the government-funded Riken institute, during a press conference in Osaka on April 9, 2014. Obokata, at the center of a controversy involving STAP cells, or stimulus-triggered acquisition of pluripotency cells, issued a statement through her lawyer on April 14, saying she "produced STAP cells almost every day and often a few times in one day."

  • Product Code
  • ILEA001197724
  • Registered date
  • 2014/4/14 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2014 Kyodo News
  • Media size
  • 559 × 857 pixel
  • Resolution
  • dpi
  • Deployment size
  • 54.98(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Retina transplants via donor iPS cells

    Retina transplants via donor iPS cells

    Masayo Takahashi, a researcher at the Japanese government-backed Riken institute, speaks at an academic conference in Tokyo on April 18, 2019. Five patients suffering a severe eye disease were doing well a year after they received in 2017 the world's first transplant surgeries using induced pluripotent stem cells from donors, she said. (Kyodo) ==Kyodo
      Retina transplants via donor iPS cells

      Retina transplants via donor iPS cells

      Photo taken Nov. 10, 2017, shows Masayo Takahashi, a researcher at the Japanese government-backed Riken institute. She said in Tokyo on April 18, 2019 that five patients suffering a severe eye disease were doing well a year after they received in 2017 the world's first transplant surgeries using induced pluripotent stem cells from donors. (Kyodo) ==Kyodo
        Riken to ask Obokata to return 600,000 yen paper submission fee

        Riken to ask Obokata to return 600,000 yen paper submission fee

        TOKYO, March 20 Kyodo - Undated photo shows Haruko Obokata, who resigned from the Riken research institute in December 2014 in the wake of a scandal over her misconduct in a so-called STAP stem-cell study. Riken announced on March 20, 2015, it plans to demand that Obokata return about 600,000 yen in research paper submission fees.
          Obokata fails to file appeal after panel condemns "STAP cell" study

          Obokata fails to file appeal after panel condemns "STAP cell" study

          TOKYO, Japan - Photo shows Haruko Obokata, a former researcher with the Riken research institute. The institute said on Jan. 6, 2015, that Obokata has not filed an appeal in response to a panel investigation finding in December, 2014 that "STAP cells" she claimed to have created almost certainly did not exist.
            Obokata fails to file appeal after panel condemns "STAP cell" study

            Obokata fails to file appeal after panel condemns "STAP cell" study

            TOKYO, Japan - Photo shows Haruko Obokata, a former researcher with the Riken research institute. The institute said on Jan. 6, 2015, that Obokata has not filed an appeal in response to a panel investigation finding in December, 2014 that "STAP cells" she claimed to have created almost certainly did not exist. (Kyodo)
              Purported "STAP cells" likely came from embryonic stem cells

              Purported "STAP cells" likely came from embryonic stem cells

              TOKYO, Japan - Haruko Obokata, then a researcher with the Riken research institute, announces the creation of the "STAP cells," claimed to be capable of developing into any type of tissue, in Kobe, western Japan, in this file photo taken in January 2014. A panel under the government-backed institute said Dec. 26, 2014, that the STAP cells that Obokata claimed to have created were likely cells generated from embryonic stem cells. Obokata left her job at Riken on Dec. 21.
                Purported "STAP cells" likely came from embryonic stem cells

                Purported "STAP cells" likely came from embryonic stem cells

                TOKYO, Japan - Isao Katsura (L), director general of the National Institute of Genetics and leader of a panel under the Riken research institute, attends a press conference along with other panel members in Tokyo on Dec. 26, 2014, to announce that the "STAP cells" that scientist Haruko Obokata, who left Riken on Dec. 21, claimed to have created were likely cells generated from embryonic stem cells. (Kyodo)
                  Purported "STAP cells" likely came from embryonic stem cells

                  Purported "STAP cells" likely came from embryonic stem cells

                  TOKYO, Japan - Haruko Obokata, then a researcher with the Riken research institute, announces the creation of the "STAP cells," claimed to be capable of developing into any type of tissue, in Kobe, western Japan, in this file photo taken in January 2014. A panel under the government-backed institute said Dec. 26, 2014, that the STAP cells that Obokata claimed to have created were likely cells generated from embryonic stem cells. Obokata left her job at Riken on Dec. 21. (Kyodo)
                    Purported "STAP cells" likely came from embryonic stem cells

                    Purported "STAP cells" likely came from embryonic stem cells

                    TOKYO, Japan - Isao Katsura, director general of the National Institute of Genetics and leader of a panel under the Riken research institute, attends a press conference in Tokyo on Dec. 26, 2014, to announce that the "STAP cells" that scientist Haruko Obokata, who left Riken on Dec. 21, claimed to have created were likely cells generated from embryonic stem cells.
                      Purported "STAP cells" likely came from embryonic stem cells

                      Purported "STAP cells" likely came from embryonic stem cells

                      TOKYO, Japan - Isao Katsura (far R), director general of the National Institute of Genetics and leader of a panel under the Riken research institute, attends a press conference along with other panel members in Tokyo on Dec. 26, 2014, to announce that the "STAP cells" that scientist Haruko Obokata, who left Riken on Dec. 21, claimed to have created were likely cells generated from embryonic stem cells.